Tadataka Yamada - May 28, 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
/s/ Glenna Mileson, attorney-in-fact on behalf of Tadataka Yamada
Stock symbol
ATHA
Transactions as of
May 28, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 06:13 PM
Previous filing
May 28, 2021
Next filing
Jul 28, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +13.9K $0.00 13.9K May 28, 2021 Common Stock 13.9K $19.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of (i) May 28, 2022, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 28, 2021.